Supplementation with Resveratrol and Curcumin Does Not Affect the Inflammatory Response to a High-Fat Meal in Older Adults with Abdominal Obesity: A Randomized, Placebo-Controlled Crossover Trial

J Nutr. 2018 Mar 1;148(3):379-388. doi: 10.1093/jn/nxx072.


Background: High-fat meals induce postprandial inflammation. Resveratrol is a polyphenol known to prevent comorbidities associated with cardiovascular disease and exerts an anti-inflammatory action. There is also an increasing body of evidence supporting the role of curcumin, a polyphenol from the curcuminoid family, as a modulator of proinflammatory processes.

Objective: The objectives of this study were to investigate the following: 1) the bioavailability of resveratrol consumed in combination with curcumin after consumption of a high-fat meal; and 2) the acute combined effects of this combination on the postprandial inflammatory response of subjects with abdominal obesity.

Methods: In a double blind, crossover, randomized, placebo-controlled study, 11 men and 11 postmenopausal women [mean ± SD age: 62 ± 5 y; mean ± SD body mass index (in kg/m2): 29 ± 3] underwent a 6-h oral fat tolerance test on 2 occasions separated by 1-2 wk: once after consumption of a dietary supplement (200 mg resveratrol and 100 mg curcumin, Res/Cur) and once after consumption of a placebo (cellulose). Plasma concentrations of total resveratrol and its major metabolites as well as inflammatory markers, adhesion molecules, and whole blood NFκB1 and PPARA gene expression were measured during both fat tolerance tests.

Results: Kinetics of resveratrol and identified metabolites revealed rapid absorption patterns but also relatively limited bioavailability based on free resveratrol concentrations. Supplementation with Res/Cur did not modify postprandial variations in circulating inflammatory markers (C-reactive protein, IL-6, IL-8, monocyte chemoattractant protein-1) and adhesion molecules [soluble E-selectin, soluble vascular cell adhesion molecule-1 (sVCAM-1), soluble intercellular adhesion molecule-1] compared to placebo (PTreatment×Time > 0.05). However, Res/Cur significantly decreased the cumulative postprandial response of sVCAM-1, compared to placebo (incremental area under the curve -4643%, P = 0.01). Postprandial variations of whole-blood PPARA and NFKB1 gene expression were not different between Res/Cur and placebo treatments.

Conclusions: Acute supplementation with Res/Cur has no impact on the postprandial inflammation response to a high-fat meal in abdominally obese older adults. Further studies are warranted to examine how resveratrol and curcumin may alter the vascular response to a high-fat meal. This trial was registered at as NCT01964846.

Publication types

  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Anti-Inflammatory Agents / pharmacology
  • Area Under Curve
  • Biological Availability
  • C-Reactive Protein / metabolism
  • Chemokine CCL2 / blood
  • Cross-Over Studies
  • Curcumin / metabolism
  • Curcumin / pharmacology*
  • Dietary Fats / administration & dosage
  • Dietary Fats / adverse effects*
  • Dietary Supplements*
  • Double-Blind Method
  • Drug Combinations
  • Female
  • Humans
  • Inflammation / blood
  • Inflammation / etiology*
  • Inflammation Mediators / blood*
  • Interleukins / blood
  • Male
  • Middle Aged
  • Obesity, Abdominal / complications*
  • PPAR alpha / blood
  • Plant Extracts / pharmacology
  • Postprandial Period
  • Resveratrol / metabolism
  • Resveratrol / pharmacology*


  • Anti-Inflammatory Agents
  • Chemokine CCL2
  • Dietary Fats
  • Drug Combinations
  • Inflammation Mediators
  • Interleukins
  • PPAR alpha
  • Plant Extracts
  • C-Reactive Protein
  • Curcumin
  • Resveratrol

Associated data